Multiple sclerosis trials recruiting in Colorado

All Multiple sclerosis trials nationally

Cities in Colorado

Recruiting trials in Colorado

• A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
  NCT07403188 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Denver
• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
  NCT06433752 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora, Basalt, Colorado Springs, Denver
• A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
  NCT07225504 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Colorado: Aurora
• A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
  NCT06782490 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Colorado: Aurora
• An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
  NCT07224373 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Colorado: Aurora
• Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
  NCT04047628 · Phase: Phase 3 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Colorado: Aurora
• Blood Flow Restriction And Veterans With MS
  NCT05433103 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · Colorado: Aurora
• Care in Multiple Sclerosis (MS)
  NCT07011914 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• Home Based Infusions for Ocrelizumab
  NCT04650321 · Phase: Phase 4 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Colorado: Centennial
• Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
  NCT07325292 · Phase: Phase 3 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Colorado: Fort Collins
• Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
  NCT05658497 · Phase: Not specified · Ages: No age limits stated · Sex: Female · Colorado: Aurora
• Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
  NCT06529406 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · Colorado: Aurora
• RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
  NCT07002034 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Colorado: Aurora
• Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS
  NCT05500963 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · Colorado: Boulder
• Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
  NCT05104983 · Phase: Phase 2 · Ages: 1 Day to 6 Months · Sex: All (male and female) · Colorado: Aurora
• Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
  NCT05877963 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Colorado: Fort Collins
• TSC Biosample Repository and Natural History Database
  NCT05676099 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Colorado: Denver